Volume 75, Issue 4, Pages (February 2009)

Slides:

Advertisements

Similar presentations

Renal disease and hypertension in non–insulin-dependent diabetes mellitus Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz Kidney International.

Advertisements

Volume 69, Issue 2, Pages (February 2017)

Beta blockers in the management of chronic kidney disease

Frederik Persson, Peter Rossing Kidney International Supplements

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Volume 66, Issue 1, Pages (July 2004)

Shining light on vitamin D trials in chronic kidney disease

Volume 72, Issue 5, Pages (September 2007)

Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes Thomas Mueller,

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Volume 75, Issue 10, Pages (May 2009)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

How to interpret the eGFR in patients with small body surface area

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

Long-term outcomes in nondiabetic chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Volume 70, Issue 12, Pages (December 2006)

Volume 87, Issue 4, Pages (April 2015)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 75, Issue 1, Pages (January 2009)

Volume 71, Issue 6, Pages (March 2007)

Volume 73, Issue 12, Pages (June 2008)

Susan Vickery, PhD, Edmund J. Lamb, PhD, R. Ian John, MBBChir, Nasir A

Should kidney donors be genotyped for APOL1 risk alleles?

Volume 76, Issue 6, Pages (September 2009)

Günter Weiss, Florian Kronenberg Kidney International

Alfonso M. Cueto-Manzano, Héctor R

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Methods for guideline development

Volume 79, Issue 9, Pages (May 2011)

Thomas Mueller, Benjamin Dieplinger Kidney International

Volume 71, Issue 6, Pages (March 2007)

Volume 87, Issue 1, Pages (January 2015)

Volume 76, Issue 8, Pages (October 2009)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 77, Issue 12, Pages (June 2010)

Volume 67, Issue 1, Pages (January 2005)

Cardio-Kidney-Damage: a unifying concept

Volume 69, Issue 1, Pages (January 2006)

Volume 80, Issue 10, Pages (November 2011)

Volume 65, Issue 2, Pages (February 2004)

Is it the low-protein diet or simply the salt restriction?

The hypothesis that abnormal BH4 metabolism impairs kidney function

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 70, Issue 3, Pages (August 2006)

Volume 69, Issue 8, Pages (April 2006)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Presentation transcript:

Volume 75, Issue 4, Pages 408-414 (February 2009) Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study Benjamin Dieplinger, Thomas Mueller, Barbara Kollerits, Joachim Struck, Eberhard Ritz, Arnold von Eckardstein, Meinhard Haltmayer, Florian Kronenberg Kidney International Volume 75, Issue 4, Pages 408-414 (February 2009) DOI: 10.1038/ki.2008.560 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Prediction of chronic kidney disease progression. Receiver-operating characteristic (ROC) plot demonstrating the ability of GFR, NT-proBNP, MR-proANP, and MR-proADM to predict kidney disease progression in patients with CKD; the areas under curve were 0.838 for GFR (black line), 0.752 for NT-prBNP (red line), 0.810 for MR-proANP (green line), and 0.876 for MR-proADM (blue line). Kidney International 2009 75, 408-414DOI: (10.1038/ki.2008.560) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Prediction of chronic kidney disease progression. Kaplan–Meier plots showing renal disease progression in patients with CKD who were stratified into two groups according to the medians of baseline GFR (54 ml/min per 1.73 m2, a), NT-proBNP (119 ng/l, b), MR-proANP (106 pmol/l, c), and MR-proADM (0.75 nmol/l, d) at baseline. Kidney International 2009 75, 408-414DOI: (10.1038/ki.2008.560) Copyright © 2009 International Society of Nephrology Terms and Conditions